Identification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of

Jane Yi Lin Tan1, Nagy A Habib2, York Wieo Chuah3

  • 1School of Chemical and Biomedical Engineering, College of Engineering, Nanyang Technological University, Singapore, Singapore.

Plos One
|April 23, 2015
PubMed

Insights

MicroRNAs regulate cellular processes by binding mRNA. This study identifies miR-181a targets, cyclin-dependent kinase inhibitor 1B and E2F7, revealing its role in hepatocellular carcinoma and MAPK/JNK pathway activation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular processes, primarily through mRNA binding and subsequent protein expression repression.
  • Understanding specific miRNA targets is crucial for elucidating their roles in cellular functions, yet remains a significant knowledge gap.
  • Aberrant miRNA expression, including miR-181a, is implicated in diseases like hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To identify specific mRNA targets of miR-181a using bioinformatics analysis.
  • To experimentally validate the binding interactions between miR-181a and its predicted targets.
  • To investigate the functional consequences of miR-181a targeting on cellular pathways, specifically the MAPK/JNK pathway.

Main Methods:

  • Bioinformatics analysis to predict potential mRNA targets of miR-181a.
  • Surface Plasmon Resonance (SPR) to validate direct binding between miR-181a and the 3'UTRs of candidate mRNA targets.
  • In vivo luciferase assay in HepG2 cells to confirm miR-181a:mRNA interactions.
  • Investigation of the MAPK/JNK signaling pathway activation in response to miR-181a expression and inhibition.

Main Results:

  • Cyclin-dependent kinase inhibitor 1B (CDKN1β) and transcriptional factor E2F7 were identified as potential targets of miR-181a.
  • SPR and luciferase assays confirmed direct binding of miR-181a to the 3'UTRs of CDKN1β and E2F7 mRNA.
  • miR-181a significantly activated the MAPK/JNK pathway, which is involved in cell proliferation; inhibition of miR-181a abolished this activation.

Conclusions:

  • This study successfully identified CDKN1β and E2F7 as direct targets of miR-181a.
  • The findings demonstrate miR-181a's role in activating the MAPK/JNK pathway, impacting cell proliferation.
  • The identification of specific miRNA targets provides a foundation for targeted functional analyses and potential therapeutic strategies in diseases like HCC.